Auflistung nach Autor "Krumbholz, Markus"

Anzeige der Dokumente 1-20 von 20

Age-dependent favorable visual recovery despite significant retinal atrophy in pediatric MOGAD: how much retina do you really need to see well?

Krumbholz, Markus (2021)
Apheresis therapies for NMOSD attacks A retrospective study of 207 therapeutic interventions

Krumbholz, Markus; Ziemann, Ulf; Zeltner, Lena (2018)
Computed tomography perfusion imaging-guided intravenous thrombolysis in acute minor ischemic stroke

Sartor-Pfeiffer, Jennifer; Lingel, Mirjam; Stefanou, Maria-Ioanna; Krumbholz, Markus; Hennersdorf, Florian; Ernemann, Ulrike; Poli, Sven; Feil, Katharina; Ziemann, Ulf; Mengel, Annerose (2023)
Cytokine and immune cell profiling in the cerebrospinal fluid of patients with neuro-inflammatory diseases

Krumbholz, Markus; Kowarik, Markus (2019)
Differential effects of disease modifying drugs on peripheral blood B cell subsets: A cross sectional study in multiple sclerosis patients treated with interferon-beta, glatiramer acetate, dimethyl fumarate, fingolimod or natalizumab

Ruschil, Christoph; Kemmerer, Constanze Louisa; Abdelhak, Ahmed; Scholl, Matthias; Ziemann, Ulf; Krumbholz, Markus; Kowarik, Markus (2020)
Efficacy of glatiramer acetate in neuromyelitis optica spectrum disorder: a multicenter retrospective study

Krumbholz, Markus; Zeltner, Lena (2016)
Endogenous soluble receptors sBCMA and sTACI: biomarker, immunoregulator and hurdle for therapy in multiple myeloma

Krumbholz, Markus (2021)
Explorative study of emerging blood biomarkers in progressive multiple sclerosis (EmBioProMS): Design of a prospective observational multicentre pilot study

Abdelhak, Ahmed; Krumbholz, Markus; Kowarik, Markus; Ziemann, Ulf (2020)
Features of Human CD3(+)CD20(+) T Cells

Krumbholz, Markus (2016)
Fingolimod induces neuroprotective factors in human astrocytes

Krumbholz, Markus (2015)
Immunotherapies in neuromyelitis optica spectrum disorder: efficacy and predictors of response

Krumbholz, Markus; Ziemann, Ulf; Zeltner, Lena (2017)
Nerve Ultrasound Predicts Treatment Response in Chronic Inflammatory Demyelinating Polyradiculoneuropathy-a Prospective Follow-Up

Ross, Marlene; Dammeier, Nele Maria; Auffenberg, Eva; Koch, Marilin; Krumbholz, Markus; Bornemann, Antje; Lerche, Holger; Winter, Natalie; Grimm, Alexander; Härtig, Florian; Rattay, Tim Wilfried (2018)
Neuromyelitis optica: Evaluation of 871 attacks and 1,153 treatment courses

Krumbholz, Markus; Zeltner, Lena; Ziemann, Ulf (2016)
Ocrelizumab Treatment in Patients with Primary Progressive Multiple Sclerosis: Short-term Safety Results from a Compassionate Use Programme in Germany

Krumbholz, Markus (2020)
Pathogenicity of human antibodies against myelin oligodendrocyte glycoprotein

Krumbholz, Markus (2018)
Patient-reported outcome parameters and disability worsening in progressive multiple sclerosis

Krumbholz, Markus; Ziemann, Ulf; Kowarik, Markus (2024)
Pro-inflammatory pattern of IgG1 Fc glycosylation in multiple sclerosis cerebrospinal fluid

Krumbholz, Markus (2015)
Serum Neurofilament Light Chain and Glial Fibrillary Acidic Protein as Biomarkers in Primary Progressive Multiple Sclerosis and Hereditary Spastic Paraplegia Type 4

Kessler, Christoph; Ruschil, Christoph; Wilke, Carlo; Krumbholz, Markus; Kowarik, Markus; Schüle, Rebecca (2022)
The Glycosylation Site of Myelin Oligodendrocyte Glycoprotein Affects Autoantibody Recognition in a Large Proportion of Patients

Krumbholz, Markus (2019)
TSPO PET imaging of natalizumab-associated progressive multifocal leukoencephalopathy

Krumbholz, Markus (2021)

Anzeige der Dokumente 1-20 von 20

Veröffentlichen

Stöbern

Gesamter Bestand

Mein Benutzerkonto

Einloggen

Auflistung nach Autor "Krumbholz, Markus"

Auflistung nach Autor "Krumbholz, Markus"

Stöbern

Gesamter Bestand

Mein Benutzerkonto

Hilfe & Infos